{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-25-000018","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2025-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.239169+00:00","generated_at":"2026-05-26T08:56:13.164596+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Evolent Q4 2024 revenue $646.5M (+16.3% YoY); net loss $30.6M, adjusted EBITDA $22.6M","bullets":["Revenue $2,554.7M full year 2024, +30.1% YoY; net loss $93.5M, net loss margin (3.7)%.","Adjusted EBITDA $160.5M full year 2024, margin 6.3%; Q4 adjusted EBITDA $22.6M, margin 3.5%.","Signed contract amendments in all three Performance Suite negotiations, expected $115M annual improvement for 2025 vs Q4 2024.","100% retention across top customers representing over 90% of 2024 revenue; new revenue agreements announced in Q4.","Average Performance Suite lives on platform 7,145 in Q4, average PMPM fee $21.32."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-25-000018","json":"https://secwatch.observer/filing/0001628908-25-000018.json","markdown":"https://secwatch.observer/filing/0001628908-25-000018.md","text":"https://secwatch.observer/filing/0001628908-25-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000018/0001628908-25-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000018/evh-20250220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T08:56:13.164596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}